Literature DB >> 15282283

Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice.

Carolien van Rijnsoever1, Marcus Täuber, Mohamed Khaled Choulli, Ruth Keist, Uwe Rudolph, Hanns Mohler, Jean Marc Fritschy, Florence Crestani.   

Abstract

Despite its pharmacological relevance, the mechanism of the development of tolerance to the action of benzodiazepines is essentially unknown. The acute sedative action of diazepam is mediated via alpha1-GABA(A) receptors. Therefore, we tested whether chronic activation of these receptors by diazepam is sufficient to induce tolerance to its sedative action. Knock-in mice, in which thealpha1-,alpha2-,alpha3-, oralpha(5)-GABA(A) receptors had been rendered insensitive to diazepam by histidine-arginine point mutation, were chronically treated with diazepam (8 d; 15 mg x kg(-1) x d(-1)) and tested for motor activity. Wild-type, alpha2(H101R), and alpha3(H126R) mice showed a robust diminution of the motor-depressant drug action. In contrast, alpha5(H105R) mice failed to display any sedative tolerance. alpha1(H101R) mice showed no alteration of motor activity with chronic diazepam treatment. Autoradiography with [3H]flumazenil revealed no change in benzodiazepine binding sites. However, a decrease in alpha5-subunit radioligand binding was detected selectively in the dentate gyrus with specific ligands. This alteration was observed only in diazepam-tolerant animals, indicating that the manifestation of tolerance to the sedative action of diazepam is associated with a downregulation of alpha5-GABA(A) receptors in the dentate gyrus. Thus, the chronic activation of alpha(5)-GABA(A) receptors is crucial for the normal development of sedative tolerance to diazepam, which manifests itself in conjunction with alpha1-GABA(A) receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282283      PMCID: PMC6729721          DOI: 10.1523/JNEUROSCI.1067-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Autoradiographic localization of alpha5 subunit-containing GABAA receptors in rat brain.

Authors:  C Sur; L Fresu; O Howell; R M McKernan; J R Atack
Journal:  Brain Res       Date:  1999-03-20       Impact factor: 3.252

2.  Molecular and neuronal substrate for the selective attenuation of anxiety.

Authors:  K Löw; F Crestani; R Keist; D Benke; I Brünig; J A Benson; J M Fritschy; T Rülicke; H Bluethmann; H Möhler; U Rudolph
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  Preexposure to drug administration context blocks the development of tolerance to sedative effects of diazepam.

Authors:  R H Marin; M F Pérez; D G Duero; O A Ramirez
Journal:  Pharmacol Biochem Behav       Date:  1999-11       Impact factor: 3.533

4.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

Authors:  U Rudolph; F Crestani; D Benke; I Brünig; J A Benson; J M Fritschy; J R Martin; H Bluethmann; H Möhler
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

5.  Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms.

Authors:  N J Ali; R W Olsen
Journal:  J Neurochem       Date:  2001-12       Impact factor: 5.372

6.  GABA(A) receptor gene expression in rat cortex: differential effects of two chronic diazepam treatment regimes.

Authors:  M I Arnot; M Davies; I L Martin; A N Bateson
Journal:  J Neurosci Res       Date:  2001-06-15       Impact factor: 4.164

Review 7.  Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal.

Authors:  A N Bateson
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

8.  Down-regulation of benzodiazepine binding to alpha 5 subunit-containing gamma-aminobutyric Acid(A) receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region.

Authors:  M Li; A Szabo; H C Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

9.  Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

Authors:  R M McKernan; T W Rosahl; D S Reynolds; C Sur; K A Wafford; J R Atack; S Farrar; J Myers; G Cook; P Ferris; L Garrett; L Bristow; G Marshall; A Macaulay; N Brown; O Howell; K W Moore; R W Carling; L J Street; J L Castro; C I Ragan; G R Dawson; P J Whiting
Journal:  Nat Neurosci       Date:  2000-06       Impact factor: 24.884

10.  Molecular targets for the myorelaxant action of diazepam.

Authors:  F Crestani; K Löw; R Keist; M Mandelli; H Möhler; U Rudolph
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

View more
  45 in total

1.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

2.  Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.

Authors:  Manish Kumar; Glenn H Dillon
Journal:  Eur J Pharmacol       Date:  2016-02-09       Impact factor: 4.432

Review 3.  Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes.

Authors:  Kiersten S Smith; Uwe Rudolph
Journal:  Neuropharmacology       Date:  2011-07-27       Impact factor: 5.250

4.  Maintenance time of sedative effects after an intravenous infusion of diazepam: a guide for endoscopy using diazepam.

Authors:  Mitsushige Sugimoto; Takahisa Furuta; Akiko Nakamura; Naohito Shirai; Mutsuhiro Ikuma; Shingen Misaka; Shinya Uchida; Hiroshi Watanabe; Kyoichi Ohashi; Takashi Ishizaki; Akira Hishida
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 5.  GABA(A) receptors and alcohol.

Authors:  Ingrid A Lobo; R Adron Harris
Journal:  Pharmacol Biochem Behav       Date:  2008-03-14       Impact factor: 3.533

6.  Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.

Authors:  Laura M Hodges; Abby J Fyer; Myrna M Weissman; Mark W Logue; Fatemeh Haghighi; Oleg Evgrafov; Allessandro Rotondo; James A Knowles; Steven P Hamilton
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

Review 7.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

8.  Context dependent benzodiazepine modulation of GABA(A) receptor opening frequency.

Authors:  Matt T Bianchi
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

9.  Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?

Authors:  Miroslav M Savić; Samarpan Majumder; Shengming Huang; Rahul V Edwankar; Roman Furtmüller; Srdan Joksimović; Terry Clayton; Joachim Ramerstorfer; Marija M Milinković; Bryan L Roth; Werner Sieghart; James M Cook
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-01-13       Impact factor: 5.067

10.  Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models.

Authors:  Felix M Rivas; James P Stables; Lauren Murphree; Rahul V Edwankar; Chitra R Edwankar; Shengming Huang; Hiteshkumar D Jain; Hao Zhou; Samarpan Majumder; Subramanian Sankar; Bryan L Roth; Joachim Ramerstorfer; Roman Furtmüller; Werner Sieghart; James M Cook
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.